GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Return on Assets [ROA] (2009 - 2026)

Updated

Gsk (GSK) recorded Return on Assets [ROA] of 4.26% in the quarter ended Jun 30, 2026, down 3.19 percentage points from 7.45% a year earlier and down 3.21 percentage points from the prior quarter.

Analysis

Gsk (GSK) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Gsk reported Return on Assets [ROA] of 10.59%, up 5.54 percentage points from the prior year.

  • Annual Return on Assets [ROA] has a five-year change of +2.59 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Assets [ROA] came in at 5.05% in the year ended Dec 31, 2024 (-3.88 pp), 8.93% in the year ended Dec 31, 2023 (-12.16 pp), 21.10% in the year ended Dec 31, 2022 (+14.49 pp) and 6.61% in the year ended Dec 31, 2021 (-1.39 pp).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Return on Assets [ROA] since the quarter ended Mar 31, 2018.
  • On a year-over-year basis, Return on Assets [ROA] rose in three of the last eight quarters, with an average year-over-year change of -2.68 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 37.79 percentage points in the quarter ended Dec 31, 2022, against a drop of 35.54 percentage points in the quarter ended Dec 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at 7.47% (quarter ended Mar 31, 2026), 7.26% (quarter ended Dec 31, 2025) and 11.68% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 10.47%
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 4.65%
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 2.45%
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 10.60%
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 9.10%
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 9.29%
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -6.13%
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 2.14%
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 5.53%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.53%
Mar 31, 2026 8.75%
Dec 31, 2025 8.56%
Sep 30, 2025 12.61%
Jun 30, 2025 8.42%
Mar 31, 2025 7.64%
Dec 31, 2024 6.56%
Sep 30, 2024 5.48%
Jun 30, 2024 8.05%
Mar 31, 2024 8.13%
Dec 31, 2023 8.79%
Sep 30, 2023 26.83%
Jun 30, 2023 42.79%
Mar 31, 2023 42.44%
Dec 31, 2022 43.78%
Sep 30, 2022 19.70%
Jun 30, 2022 8.29%
Mar 31, 2022 9.81%
Dec 31, 2021 6.53%
Sep 30, 2021 4.86%
API Access

Gsk Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY